Specifically, ERO1L predicted a poor prognosis in ACC (HR = 2.3; P = 0.04), CESC (HR = 2.0; P = 0.0038), KICH (HR = 9.2; P = 0.011), KIRP (HR = 2.3; P = 0.0089), LIHC (HR = 1.6; P = 0.0069), LUAD (HR = 2.2; P < 0.0001), MESO (HR = 1.8; P = 0.02), and PAAD (HR = 1.6; P = 0.022) (Figure 1E). The gene discussed is ERO1A; the disease is adrenal cortex carcinoma.